Format

Send to

Choose Destination
Exp Ther Med. 2017 Dec;14(6):5569-5575. doi: 10.3892/etm.2017.5238. Epub 2017 Sep 29.

Neuroprotective effects of astragaloside IV on Parkinson disease models of mice and primary astrocytes.

Author information

1
Department of Neurology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, P.R. China.
2
Department of Geriatrics, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, P.R. China.

Abstract

Parkinson's disease (PD) is characterized by a progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta. Inflammation and neural degeneration are implicated in the pathogenesis of PD. Astragaloside IV (AS-IV) has been verified to attenuate inflammation. The current study aimed to investigate the role of AS-IV in PD and the possible molecular mechanisms. Pole, traction and swim tests were performed to examine the effects of AS-IV on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-generated behavioral deficiencies in vivo. Meanwhile, as for in vitro experiments, the influence of AS-IV on cell viability was evaluated using the 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay, the effects of AS-IV on 1-methyl-4-phenylpyridnium ion (MPP+)-induced cell viability changes were tested using MTT assays, cell apoptosis rates were assessed using an Annexin-V Fluorescein isothiocyanate kit, and the expression levels of phosphorylated-Jun N-terminal kinase (p-JNK), Bcl-2-associated X protein (Bax)/Bcl-2 and caspase-3 activity were assessed using western blot analysis. Behavioral tests showed that pretreatment of AS-IV significantly alleviated MPTP-generated behavioral deficiencies in vivo. Meanwhile, AS-IV remarkably rescued MPP+-induced cell viability reduction, increase in cell apoptosis rate, and upregulation of p-JNK, Bax/Bcl-2 ratio and caspase-3 activity in vitro. In conclusion, AS-IV may be a promising neuroprotective agent for PD.

KEYWORDS:

Parkinson's disease; astragaloside IV; astrocytes

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center